NCMAG 128 Pazopanib: July 2026
Posted on:
Document Type
NCMAG advice
Process guidance
Summary
For the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma who have received prior chemotherapy for metastatic disease or who have progressed within 12 months of (neo) adjuvant therapy.
Decision: this on-label use of an off-patient medicine is supported.